Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
57.1M
-
Number of holders
-
59
-
Total 13F shares, excl. options
-
28M
-
Shares change
-
-593K
-
Total reported value, excl. options
-
$998M
-
Value change
-
-$18.7M
-
Number of buys
-
42
-
Number of sells
-
-26
-
Price
-
$36.15
Significant Holders of Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) as of Q4 2020
73 filings reported holding HRMY - Harmony Biosciences Holdings, Inc. - Common Stock as of Q4 2020.
Harmony Biosciences Holdings, Inc. - Common Stock (HRMY) has 59 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28M shares
of 57.1M outstanding shares and own 48.94% of the company stock.
Largest 10 shareholders include FMR LLC (7.93M shares), Vivo Capital, LLC (4.53M shares), Novo Holdings A/S (3.62M shares), venBio Partners LLC (3.5M shares), Newlight Partners LP (2.67M shares), JANUS HENDERSON GROUP PLC (1.09M shares), Aisling Capital Management LP (843K shares), MASSACHUSETTS FINANCIAL SERVICES CO /MA/ (514K shares), PERCEPTIVE ADVISORS LLC (503K shares), and BlackRock Inc. (286K shares).
This table shows the top 59 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.